Follow us on:
Issue Alert
Issue Alert
ODT Forum 2026_Leaderboard_042226

March/April 2026 Issue is Now Live!

 

Explore the Full List of Features Now >>
March/April 2026

Features

Miniaturized Molding for Orthopedic Device Manufacturing

As orthopedic device makers strive to develop smaller solutions, molded components and implants must accommodate this demand.

SPONSOR

Best Practices for Managing Patient-Specific Case Planning—An Orthopedic Innovators Q&A

Leveraging a patient-specific platform between multiple stakeholders provides enhanced communication and a better outcome for the patient.

Features

A Printer-Friendly Discussion of Orthopedic Additive Manufacturing

Cost, clinical evidence, and implant design complexity are pushing additive manufacturing into the mainstream.

Features

Orthopedic Extremity Implants Are Precision in Miniature

Rising procedure volumes, design complexity, and surgeon expectations are raising extremity device innovation and the manufacturing behind it to new heights.

Industry Voices

Built to Heal, Designed to Defend: A Q&A with Onkos Surgical’s CEO

Onkos Surgical founder and CEO Patrick Treacy discusses bacterial contamination strategy and the company’s future.

Editorial

Walking in Memphis for the ODT Forum 2026

Memphis is second only to the Warsaw region for orthopedic device manufacturing in the U.S.

Orthopedic Insights

From the Big Easy to the Big Picture: Key AAOS 2026 Takeaways

The lasting impression from AAOS 2026 is that the orthopedic industry is not waiting for the future.

Advancing Additive

Personalization in Orthopedic Device Design: Scaling is the New Differentiator

When it comes to patient-specific planning, guides, or implants, personalization has moved out of the innovation spotlight.

Market Snapshot

Physicians: Designing for the Clinicians Who Bring Your Technology to Life

Physicians' daily work determines whether your innovation becomes part of real-world care.

Best Practices

Future-Ready Quality: What High-Performing QA Teams Will Look Like in 2026

The QA/RA teams that succeed in 2026 won’t be the ones with the largest departments. They’ll be the ones built for agility.

The Last Word

As Others Exit Spine, Medtronic Leans In

Since the spine divestment speculations began, Big Blue has ignored the noise and invested heavily in its spine portfolio.

Featured Resources

Solution Centers SPOTLIGHT

Evonik Industries AG

Evonik offers a broad portfolio of biomaterials for medical devices that meet the highest standards of biocompatibility, biostability, and performance. Our biomaterials support innovation in medical devices, from short-term to long-term implantable devices, while our bioresorbable medical polymers enable controlled degradation, opening further possibilities for medical device applications. With decades of experience in polymer science and medical-grade material development, Evonik is a trusted partner to the global medical device industry. We offer a comprehensive range of high-performance biomaterials, including RESOMER®, VESTAKEEP®, and VECOLLAN®, each tailored to specific medical applications. Our team supports customers with customization, regulatory guidance, and global technical support, helping accelerate product development from concept to market.